适应大师:癌症和免疫细胞可塑性如何调解瘤进展
Sheera R Rosenbaum1, Kaiah M Fields1,2, Heide L Ford1,2
1Department of Pharmacology, University of Colorado Anschutz Medical Campus (AMC), Aurora, Colorado, United States of America.
PLoS biology
|July 15, 2025
概括
瘤细胞的可塑性使得癌细胞能够逃避治疗和免疫系统. 了解这种与免疫细胞的相互作用为癌症进展提供了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 瘤细胞的可塑性是癌症治疗的一个主要障碍,使癌细胞能够适应和生存.
- 瘤微环境包含多种细胞,包括免疫细胞,其可塑性可以影响瘤的进展.
- 表皮介质可塑性 (EMP) 是瘤细胞中关键的表型变化.
研究的目的:
- 讨论癌细胞和免疫细胞之间的相互可塑性.
- 专注于瘤细胞中的上皮介质可塑性.
- 探索针对这种癌症-免疫细胞相互作用的治疗策略.
主要方法:
- 关于瘤细胞可塑性和免疫细胞相互作用的当前文献的综述.
- 对表皮质-介质细胞可塑性在瘤进展中的作用的分析.
- 讨论因这种相互作用而产生的潜在治疗脆弱性.
主要成果:
- 癌细胞的可塑性,特别是EMP,有助于免疫逃避和生存.
- 瘤微环境中的免疫细胞可塑性可以被选择为促进瘤生长.
- 癌症和免疫细胞之间的动态相互作用显著推动了瘤的进展.
结论:
- 准癌症和免疫细胞的相互可塑性是一个有前途的治疗途径.
- 了解表皮-介质细胞可塑性对于开发有效的癌症治疗非常重要.
- 利用瘤微环境的可塑性可能会导致新的抗癌策略.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
Cancers Originate from Somatic Mutations in a Single Cell
12.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.9K


